Navigation Links
Watch Advancements to Learn About Innovations in Microbiome-based Therapeutics for Neurological Diseases
Date:9/7/2021

Scheduled to broadcast 1Q/2022, an upcoming episode of Advancements with Ted Danson will focus on disease modification via microbiome-derived small molecules.

In this segment, viewers will learn about gut microbiome – the sum total of microorganisms that colonize the digestive tract, and the gut-brain axis – a bidirectional link between the central nervous system (CNS) and the enteric nervous system (ENS) of the body.

The show will explore how innovations in science and technology are being used to modify disease with microbiome-derived small molecules, as it looks at Stellate Therapeutics (Stellate) – an international biotechnology company with locations in Paris and New York City, focused on the use of small molecules to treat neurodegenerative disorders.

“Stellate Therapeutics is proud to partner with Advancements to bring the emerging field of gut-brain axis and microbiome research to a wider audience. As we plan to move our lead microbiome-derived molecule, STL-101, into clinical trials next year, viewers will have a chance to learn what it takes to build a biotech company from the ground up. The microbiome has enormous potential to be a source of disease modifying therapies for many who suffer from neurological disorders (such as Parkinson’s or Alzheimer’s Diseases). We at Stellate are excited to be at the forefront of bringing these kinds of therapeutics to patients that desperately need help in managing their disease,” said David Immke, PhD, Stellate Therapeutics Chief Scientific Officer.

Spectators will see how by exploring the interaction and function of these molecules in disease states, Stellate is working to develop therapeutics that address unmet needs in a number of neurological conditions.

“95 percent of serotonin is produced in the gut and participates in the interactions between the brain and gut via the Vagus nerve,” said Colin Ferguson, producer for the Advancements series. “We are excited to explore how Stellate is using science to create therapeutics for neurodevelopmental, psychological, and neurodegenerative brain diseases.”

About Stellate Therapeutics:
Stellate Therapeutics is a private global biotechnology company that develops small molecules produced by the microbiome into first-in-class therapies for neurological diseases (Parkinson’s and Alzheimer’s diseases). Stellate is also evaluating a portfolio of new drug candidates in other conditions, with capabilities across discovery, screening, production and diagnostic development.

For more information, visit: https://stellate-tx.com/.

About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-4065.

Read the full story at https://www.prweb.com/releases/watch_advancements_to_learn_about_innovations_in_microbiome_based_therapeutics_for_neurological_diseases/prweb18173943.htm.


'/>"/>
Source: PRWeb
Copyright©2021 Vocus, Inc.
All rights reserved


Related biology technology :

1. Watching fluid flow at nanometer scales
2. FSH Society for Muscular Dystrophy is One of “Ten Charities Worth Watching”
3. TaxOps Is a Colorado Company to Watch
4. Study Scavenger and CenterWatch Partner to Improve Patient Recruitment, Enrollment and Mobile Access to Clinical Trials with New Study Scavenger Smartphone App
5. Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015
6. Synthetic Biologics SYN-004 for the Prevention of C. difficile Infections Named a "Top Project to Watch" by Elsevier Business Intelligence
7. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
8. Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon
9. Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference
10. Elsevier Clinical Solutions Diane Bartoli Featured In Profiles in Diversity Journals 13th Annual Women Worth Watching Issue
11. Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):